Citation Impact
Citing Papers
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
2024 StandoutNobel
Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials
2015
Anti-inflammatory activity of natural dietary flavonoids
2010 Standout
Rheumatoid arthritis
2018 Standout
All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
2007
Antibodies to citrullinated α‐enolase peptide 1 are specific for rheumatoid arthritis and cross‐react with bacterial enolase
2008
Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation
2003
Rheumatoid arthritis
2016 Standout
Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis
2004
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
Immunologic Mechanisms in the Pathogenesis of Rheumatoid Arthritis
2005
Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling
2009
Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis
2006
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes
2012 StandoutNobel
The influence of age at symptom onset and length of followup on mortality in patients with recent‐onset inflammatory polyarthritis
2008
Total Mortality is Increased in Rheumatoid Arthritis. A 17-Year Prospective Study
2001
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
2016 StandoutNobel
Juvenile idiopathic arthritis
2007 Standout
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
2006
Advances in B-cell epitope analysis of autoantigens in connective tissue diseases
2003
Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis
2007
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Recent improvements in survival in patients with rheumatoid arthritis: Better outcomes or different study designs?
2001
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
2009
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Cardiovascular death in rheumatoid arthritis: A population‐based study
2005
Antibodies against cyclic citrullinated peptide are associated with HLA–DR4 in simplex and multiplex polyarticular‐onset juvenile rheumatoid arthritis
2005
Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases
2013
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease
2003
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Osteoporosis in inflammatory joint diseases
2010
Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis
2005
Neutrophil extracellular traps in immunity and disease
2017 Standout
Myocarditis
2011 Standout
Exercise as an anti-inflammatory therapy for rheumatic diseases—myokine regulation
2014
Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis
2012
Single cell sequencing identifies clonally expanded synovial CD4+ TPH cells expressing GPR56 in rheumatoid arthritis
2022
Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages
2004
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s
2005
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Mortality in early inflammatory polyarthritis: Cardiovascular mortality is increased in seropositive patients
2002
Myositis-specific autoantibodies: overview and recent developments
2001
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
2020 StandoutNobel
Rheumatoid arthritis
2010 Standout
A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice
2011 StandoutNobel
Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?
2002
Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis
2002
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis
2009
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Arthritis and bone loss
2013
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations
2004
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
2014
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA–DRB1 shared epitope for antibodies to citrullinated proteins
2005
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis
2003
The widening mortality gap between rheumatoid arthritis patients and the general population
2007
Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study
2004
Polymyositis and dermatomyositis
2003 Standout
119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands
2004 Standout
Replication of Putative Candidate-Gene Associations with Rheumatoid Arthritis in >4,000 Samples from North America and Sweden: Association of Susceptibility with PTPN22, CTLA4, and PADI4
2005
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Survival in rheumatoid arthritis: A population‐based analysis of trends over 40 years
2003
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin‐17A production
2010
Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta‐analysis of observational studies
2008 Standout
Declines in Erythrocyte Sedimentation Rates in Patients with Rheumatoid Arthritis Over the Second Half of the 20th Century
2009
The Complex Role of Estrogens in Inflammation
2007 Standout
Rheumatoid arthritis and systemic lupus erythematosus as immune complex diseases.
2009
Diagnostic Accuracy of the Anti-Citrulline Antibody Assay for Rheumatoid Arthritis
2001
Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis
2007 Nobel
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
2004
Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development.
2007 StandoutNobel
Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.
2003
Well-being in Rheumatoid Arthritis: The Effects of Disease Duration and Psychosocial Factors
2005
Guidelines for the Primary Prevention of Stroke
2014 Standout
The clinical utility of inhibiting CD28‐mediated costimulation
2009
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Tackling ischaemic heart disease in rheumatoid arthritis
2003
Prediction of mortality in rheumatoid arthritis based on disease activity markers.
2005
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
2002
Mortality in rheumatoid arthritis: 2008 update.
2009
Brief Report: Testosterone Is Protective in the Sexually Dimorphic Development of Arthritis and Lung Disease in SKG Mice
2013 StandoutNobel
Immunity to Citrullinated Proteins in Rheumatoid Arthritis
2008
Recent Advances in Defining the Genetic Basis of Rheumatoid Arthritis
2016
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of E. J. A. Kroot being referenced
Management of therapy-resistant rheumatoid arthritis
1999
The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis
2000
Diagnostic value of blind synovial biopsy in clinical practice
2005
Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease
2001
Physical activity and body composition in patients with ankylosing spondylitis
2011
No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset
2000
Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study.
2001